The Cancer Molecular Therapeutics Research Association Board of Directors is pleased to announce the location of the
2025 CMTRA conference at
The Homestead Resort in Midway, Utah.
The conference is scheduled for July 13-17, 2025.
The CMTRA would love to see you there! Registration will open in early 2025.
​
ABOUT THE CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION
The Full Story
-
Provides a dynamic platform for the most contemporary and controversial approaches to the treatment of cancer
​
-
Dedicates half of the formal presentation time to questions and answers to promote rigorous discussion
​
-
Welcomes an active dialog among investigators from industry, academia, government and, foundations
​
-
Enables informal and intimate (100 participants) networking for graduate students, postdoctoral fellows, residents and, early-stage and established investigators
​
-
Awards the top four poster presenters with the opportunity to orally present their research and attend next year’s conference free of charge
​
-
Builds on the legacy of more than two decades of annual conference
The 2022, 2023 and 2024 CMTRA Conferences have been remarkable events. The CMTRA Board and event team are excited about the 2025 Annual Conference to come!
See below for pictures from previous CMTRA Annual Conferences.
ANNUAL MEETINGS
Programs
The Cancer Molecular Therapeutics Research Association [CMTRA] was created in 2008 to organize and host the annual Molecular Therapeutics of Cancer meeting. The meeting objective is to provide a forum for presentation and discussion of contemporary research in the field of cancer drug development and therapy. Modeled after small Gordon-type conferences, the meeting provides an opportunity for young and established researchers to discuss and challenge current paradigms for cancer drug development and therapy, as well as a venue where novel ideas can be presented with anticipation of lively debate.
2023 Conference
Watkins Glen Harbor Hotel
Watkins Glen, NY
2020 Conference
Cancelled due to the COVID-19 Pandemic
2022 Conference
Skamania Lodge
Stevenson, Washington
2019 Conference
Granlibakken Tahoe Resort & Conference Center
Lake Tahoe, California
2021 Conference
Cancelled due to the COVID-19 Pandemic
2018 Conference
Sundance, Utah
2017 Conference
Hilton Burlington Hotel
Burlington, Vermont
2014 Conference
Asilomar
Pacific Grove, California
2016 Conference
University of Washington
Seattle, Washington
2013 Conference
University of Colorado
Boulder, Colorado
2015 Conference
Tufts University
Medford, Massachusetts
2012 Conference
Princeton University
Princeton, New Jersey
Officers & Board Members
CMTRA
Emeritus Board Members:
-
James D. Winkler, Ph.D. - Cheif Scientific Officer | OnKure Therapeutics | Boulder, Colorado
Mary-Ann Bjornsti, Ph.D. - Professor Department of Pharmacology & Toxicology | University of Alabama at Birmingham | Birmingham, AL -
Peter Houghton, Ph.D. - Greehey Children's Cancer Research Institute | UT Health at San Antonio | San Antonio, TX
-
Phillip Dennis, M.D., Ph.D. - Sanofi Oncology |
-
James Winkler, Ph.D. - OnKure Therapeutics | Boulder, CO
-
Robert Kramer, Ph.D. - RAKramer Consulting LLC | Newton, PA
-
Alan Eastman, Ph.D. - Professor Emeritus | Norris Cotton Cancer Center | Dartmouth College | Hanover, NH
-
John A. Hickman, D.Sc. - Agon Consulting, Paris
-
Branimir I. Sikic, M.D. - Director | Stanford Clinical & Translational Research Unit; Co-director | Stanford University School of Medicine | Stanford, CA
MARTIN MCMAHON, PH.D.
President
Cumming-Presidential Professor of Cancer Biology & Senior Director for Preclinical Translation | Huntsman Cancer Institute & Dept. of Dermatology | University of Utah | Salt Lake City, UT
LORI FRIEDMAN, PH.D.
Vice President
Chief Scientific Officer | ORIC Pharmaceuticals | South San Francisco, CA
WILLIAM J. PLACZEK, PH.D.
Treasurer
Associate Professor | Department of Biochemistry and Molecular Genetics; Director | Central Alabama High-Field NMR Facility; Co-Director | Structural Biology Shared Facility, Cancer Center | The University of Alabama at Birmingham
SHIVA MALEK, PH.D.
Board Member
Global Head, Oncology | Novartis Institute of Biomedical Research
ARIA VAISHNAVI, PH.D.
Board Member
Assistant Professor | Department of Cancer Biology | University of Texas MD Anderson Cancer Center
EMMA LEES, PH.D.
Board Member
Head, Mechanisms of Cancer Resistance Thematic Research Center | Bristol Myers Squibb
ELI M. WALLACE, PH.D.
Board Member
Chief Scientific Officer, Oncology | BridgeBio | Dallas, TX
BOB ABRAHAM, PH.D.
Board Member
Executive Vice President | Head of Cancer Biology | Odyssey Therapeutics
ZAHID H. SIDDIK, PH.D.
Board Member
Professor of Medicine | Pharmacology Department of Experimental Therapeutics | MD Anderson Cancer Center | Houston, TX
